Life Sciences IP Review

17,000+ key IP decision-makers rely on Life Sciences IP Review (LSIPR) as their daily source of news in the life sciences, biotechnology and pharmaceutical industry. LSIPR offers IP professionals a single point of contact to stay on top of industry trends and developments. No other online platform offers such in-depth or comprehensive analysis of the latest IP news in the life sciences. To access our quarterly e-magazine, daily news articles or to learn more about upcoming events, visit our website:

Follow us on: